4,5,6,7-tetrabromo-2-azabenzimidazole has been researched along with Sensitivity and Specificity in 1 studies
4,5,6,7-tetrabromobenzotriazole: a CK2 kinase inhibitor
Sensitivity and Specificity: Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
Excerpt | Relevance | Reference |
---|---|---|
"Besides cardiovascular diseases, cancer represents the major cause of death in developed countries." | 1.36 | A FRET-based microplate assay for human protein kinase CK2, a target in neoplastic disease. ( Götz, C; Gratz, A; Jose, J, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gratz, A | 1 |
Götz, C | 1 |
Jose, J | 1 |
1 other study available for 4,5,6,7-tetrabromo-2-azabenzimidazole and Sensitivity and Specificity
Article | Year |
---|---|
A FRET-based microplate assay for human protein kinase CK2, a target in neoplastic disease.
Topics: Casein Kinase II; Emodin; Enzyme Assays; Fluorescence; Fluorescence Resonance Energy Transfer; Human | 2010 |